Teladoc Health, Inc.
TDOCNYSE
$9.43
↓ -0.4%Jul 17 close · end-of-day
Price
1Y↑ +19.7%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$1.7B
Enterprise Value
$938.4M
P/E
—
P/S
0.7
P/B
1.3
EV/EBITDA
—
PEG
—
FCF Yield
16.6%
Dividend Yield
—
Revenue (TTM)
$2.5B
Net Income (TTM)
-$171.1M
Free Cash Flow (TTM)
$280.1M
Gross Margin
—
Operating Margin
-8.1%
Net Margin
-6.8%
ROE
-12.8%
ROIC
-27.5%
Debt / Equity
—
Net Cash
$750.7M
Return 1Y
+17.3%
Company profile
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions.
- CEO
- Jason N. Gorevic
- Sector
- Services
- Industry
- Healthcare
- Employees
- 5,100
- Headquarters
- New York
- Website
- teladochealth.com
Management & directors
- Bliss KellyPresident, U.S. Group Health
- Catapano Joseph RonaldChief Accounting Officer
- Divita Charles IiiCHIEF EXECUTIVE OFFICER
- Rodrigues Fernando M.President of BetterHelp
- Nueno CarlosPresident, International
- Vandervoort Adam CCHIEF LEGAL OFFICER, SECRETARY
- Murthy MalaCHIEF FINANCIAL OFFICER
Roles derived from SEC Form 4 filings.
Earnings
TDOC Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$613.8M↓ -2.5%
Diluted EPS-$0.36↓ -32.1%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $2.0B | $2.4B | $2.6B | $2.6B | $2.5B |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$506.4M | -$265.6M | -$13.7B | -$248.6M | -$1.0B | -$263.0M |
| Net income | -$485.1M | -$428.8M | -$13.7B | -$220.4M | -$1.0B | -$200.3M |
| Diluted EPS | -$5.36 | -$2.73 | -$84.60 | -$1.34 | -$5.87 | -$1.14 |
| Operating cash flow | -$53.5M | $194.0M | $189.3M | $350.0M | $293.7M | $294.4M |
| Free cash flow | -$57.5M | $185.5M | $172.8M | $338.6M | $282.9M | $285.5M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | -46.3% | -13.1% | -567.3% | -9.6% | -39.7% | -10.4% |
| Net margin | -44.3% | -21.1% | -567.5% | -8.5% | -39.0% | -7.9% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $642.4M | $640.5M | $640.5M | $629.4M | $631.9M | $626.4M | $642.3M | $613.8M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$841.1M | -$44.4M | -$48.2M | -$120.6M | -$54.4M | -$52.0M | -$36.0M | -$61.8M |
| Net income | -$837.7M | -$33.3M | -$48.4M | -$93.0M | -$32.7M | -$49.5M | -$25.1M | -$63.8M |
| Diluted EPS | -$4.92 | -$0.19 | -$0.27 | -$0.53 | -$0.19 | -$0.28 | -$0.14 | -$0.36 |
| Operating cash flow | $88.7M | $110.2M | $85.9M | $15.9M | $91.4M | $99.3M | $87.7M | $9.5M |
| Free cash flow | $86.8M | $108.6M | $79.8M | $13.2M | $90.2M | $97.0M | $85.1M | $7.9M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -130.9% | -6.9% | -7.5% | -19.2% | -8.6% | -8.3% | -5.6% | -10.1% |
| Net margin | -130.4% | -5.2% | -7.6% | -14.8% | -5.2% | -7.9% | -3.9% | -10.4% |
Company news
Jul 15, 2026
Jul 9, 2026
- 10d agoTeladoc (TDOC) Rises Higher Than Market: Key Factsfinance.yahoo.com
- 11d agoTeladoc Health (TDOC) Expands Through Walmart And NBPA Deals, Is Fair Value Still Lower?finance.yahoo.com
- 11d agoRussell Index Removal Could Be A Game Changer For Teladoc Health’s (TDOC) Investment Narrativefinance.yahoo.com
- 11d agoTeladoc Health (TDOC) Stock May Be 40% Undervalued As Insurance Coverage Expandsfinance.yahoo.com
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-06 | Bliss Kelly· President, U.S. Group Health | Sale | 2,500 | $9.50 | $23,750.00 | filing |
| 2026-07-02 | Catapano Joseph Ronald· Chief Accounting Officer | Sale | 653 | $9.10 | $5,942.30 | filing |
| 2026-07-01 | Bliss Kelly· President, U.S. Group Health | Sale | 2,500 | $9.00 | $22,500.00 | filing |
| 2026-07-01 | Catapano Joseph Ronald· Chief Accounting Officer | Option exercise | 2,083 | — | — | filing |
| 2026-06-29 | Bliss Kelly· President, U.S. Group Health | Sale | 2,500 | $8.50 | $21,250.00 | filing |
| 2026-06-11 | DIVITA CHARLES III· CHIEF EXECUTIVE OFFICER | Sale | 18,074 | $6.94 | $125,469.71 | filing |
| 2026-06-10 | DIVITA CHARLES III· CHIEF EXECUTIVE OFFICER | Option exercise | 39,160 | — | — | filing |
| 2026-06-10 | DIVITA CHARLES III· CHIEF EXECUTIVE OFFICER | Option exercise | 3,642 | — | — | filing |
| 2026-06-03 | Rodrigues Fernando M.· President of BetterHelp | Sale | 9,572 | $7.40 | $70,832.80 | filing |
| 2026-06-02 | DIVITA CHARLES III· CHIEF EXECUTIVE OFFICER | Sale | 19,132 | $7.63 | $145,919.76 | filing |
| 2026-06-02 | Vandervoort Adam C· CHIEF LEGAL OFFICER, SECRETARY | Sale | 7,906 | $7.63 | $60,299.06 | filing |
| 2026-06-02 | Bliss Kelly· President, U.S. Group Health | Sale | 7,679 | $7.63 | $58,567.73 | filing |
| 2026-06-02 | Nueno Carlos· President, International | Sale | 6,196 | $7.63 | $47,256.89 | filing |
| 2026-06-02 | Rodrigues Fernando M.· President of BetterHelp | Sale | 5,677 | $7.63 | $43,298.48 | filing |
| 2026-06-02 | Catapano Joseph Ronald· Chief Accounting Officer | Sale | 284 | $7.63 | $2,166.07 | filing |
| 2026-06-01 | Bliss Kelly· President, U.S. Group Health | Option exercise | 9,152 | — | — | filing |
| 2026-06-01 | Rodrigues Fernando M.· President of BetterHelp | Option exercise | 5,491 | — | — | filing |
| 2026-06-01 | Rodrigues Fernando M.· President of BetterHelp | Option exercise | 1,042 | — | — | filing |
| 2026-06-01 | Rodrigues Fernando M.· President of BetterHelp | Option exercise | 8,716 | — | — | filing |
| 2026-06-01 | Vandervoort Adam C· CHIEF LEGAL OFFICER, SECRETARY | Option exercise | 426 | — | — | filing |
| 2026-06-01 | Vandervoort Adam C· CHIEF LEGAL OFFICER, SECRETARY | Option exercise | 5,350 | — | — | filing |
| 2026-06-01 | Vandervoort Adam C· CHIEF LEGAL OFFICER, SECRETARY | Option exercise | 9,152 | — | — | filing |
| 2026-06-01 | Nueno Carlos· President, International | Option exercise | 4,556 | — | — | filing |
| 2026-06-01 | Nueno Carlos· President, International | Option exercise | 8,716 | — | — | filing |
| 2026-06-01 | DIVITA CHARLES III· CHIEF EXECUTIVE OFFICER | Option exercise | 1,966 | — | — | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.